NFL will fine more than 100 players for reselling Super Bowl tickets at a profit

NFL will fine more than 100 players for reselling Super Bowl tickets at a profit


A detail shot of the Lombardi Trophy next to Kansas City Chiefs and Philadelphia Eagles helmets prior to a news conference on February 03, 2025 in New Orleans, Louisiana ahead of the NFL Super Bowl LIX football game between the Philadelphia Eagles and the Kansas City Chiefs.

Kevin Sabitus | Getty Images Sport | Getty Images

The NFL is cracking down on the resale of Super Bowl tickets by players, coaches and club employees.

The league plans to fine more than 100 players and roughly two dozen club employees who were found to be in violation of the NFL’s Ticket Resale policy in connection with Super Bowl 59 tickets, according to an internal memo from the league’s chief compliance officer, Sabrina Perel, that was viewed by CNBC.

An investigation found that those players and personnel were selling these tickets to resale “bundlers” at a profit, according to the memo.

Players will be fined 1.5-times the face value of the tickets they sold, and employees will be fined twice the face value, according to a person familiar with the matter who declined to be named speaking about nonpublic details.

Non-player personnel found in violation of the policy will also lose the ability to purchase future NFL tickets, according to the memo.

The league prohibits employees and players from selling NFL game tickets acquired from their employer for more than the ticket’s face value or more than the employee originally paid — whichever is less.

The league is also taking steps to enhance compliance training ahead of Super Bowl 60 and said it will increase penalties for future offenses.

“No one should profit personally from their NFL affiliation at the expense of our fans,” Perel wrote in the memo.



Source

FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More